Actinium Pharmaceuticals, Inc. (ATNM)
Operating Cash Flow (Statement)
-$22.66M
TTM · Period ending: · USD
ATNM Operating Cash Flow (Statement)
Latest reported-$22.66Mperiod ending
Latest reported-$22.66Mperiod ending
ATNM TTM Cash from Operations (-$15.49K → -$22.66M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ATNM operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -22,663,000 | |
| -22,876,000 | |
| -24,580,000 | |
| -25,042,000 | |
| -30,692,000 | |
| -33,272,000 | |
| -33,072,000 | |
| -34,811,000 | |
| -33,961,000 | |
| -39,632,000 | |
| -47,335,000 | |
| -47,623,000 | |
| -42,213,000 | |
| -652,000 | |
| 8,644,000 | |
| 11,370,000 | |
| 11,497,000 | |
| -21,005,000 | |
| -20,866,000 | |
| -22,072,000 | |
| -21,478,000 | |
| -21,405,000 | |
| -21,617,000 | |
| -20,369,439 | |
| -20,973,957 | |
| -21,825,840 | |
| -21,461,449 | |
| -20,737,893 | |
| -21,753,384 | |
| -20,601,421 | |
| -20,571,056 | |
| -19,452,696 | |
| -18,708,685 | |
| -21,637,658 | |
| -21,553,346 | |
| -22,625,683 | |
| -22,325,811 | |
| -21,407,700 | |
| -20,789,237 | |
| -20,512,640 | |
| -18,441,774 | |
| -17,487,187 | |
| -18,543,768 | |
| -19,626,873 | |
| -20,366,927 | |
| -17,670,856 | |
| -14,348,754 | |
| -10,645,833 | |
| -8,026,668 | |
| -6,471,026 | |
| -6,292,416 | |
| -10,145,839 | |
| -8,527,430 | |
| -7,519,042 | |
| -5,212,710 | |
| -19,256 | |
| -21,030 | |
| -4,861 | |
| -2,975 | |
| -3,634 | |
| -13,301 | |
| 9,139 | |
| 7,835 | |
| 9,762 | |
| 17,713 | |
| -13,957 | |
| -18,783 | |
| -18,659 | |
| -18,283 | |
| -21,152 | |
| -13,964 | |
| -15,439 | |
| -15,238 | |
| -15,054 | |
| -15,492 | |
| -14,997 | |
| -20,374 |